BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27930740)

  • 21. Barriers and facilitators adolescent females living with HIV face in accessing contraceptive services: a qualitative assessment of providers' perceptions in western Kenya.
    Hagey JM; Akama E; Ayieko J; Bukusi EA; Cohen CR; Patel RC
    J Int AIDS Soc; 2015; 18(1):20123. PubMed ID: 26385854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation.
    Chakrapani V; Newman PA; Shunmugam M; Mengle S; Varghese J; Nelson R; Bharat S
    AIDS Patient Care STDS; 2015 Oct; 29(10):569-77. PubMed ID: 26348459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study.
    Fowler N; Arkell P; Abouyannis M; James C; Roberts L
    AIDS Patient Care STDS; 2015 Jan; 29(1):33-42. PubMed ID: 25375792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
    Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR
    AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community perceptions of childbearing and use of safer conception strategies among HIV-discordant couples in Kisumu, Kenya.
    Breitnauer BT; Mmeje O; Njoroge B; Darbes LA; Leddy A; Brown J
    J Int AIDS Soc; 2015; 18(1):19972. PubMed ID: 26077644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathways for reduction of HIV-related stigma: a model derived from longitudinal qualitative research in Kenya and Uganda.
    Camlin CS; Charlebois ED; Getahun M; Akatukwasa C; Atwine F; Itiakorit H; Bakanoma R; Maeri I; Owino L; Onyango A; Chamie G; Clark TD; Cohen CR; Kwarisiima D; Kabami J; Sang N; Kamya MR; Bukusi EA; Petersen ML; V Havlir D
    J Int AIDS Soc; 2020 Dec; 23(12):e25647. PubMed ID: 33283986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "It is always better for a man to know his HIV status" - A qualitative study exploring the context, barriers and facilitators of HIV testing among men in Nairobi, Kenya.
    Okal J; Lango D; Matheka J; Obare F; Ngunu-Gituathi C; Mugambi M; Sarna A
    PLoS One; 2020; 15(4):e0231645. PubMed ID: 32294124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral Therapy Initiation Is Not Associated With Risky Sexual Behavior Among Heterosexual Human Immunodeficiency Virus-Infected Persons in Serodiscordant Partnerships.
    Mujugira A; Celum C; Ngure K; Thomas KK; Katabira E; Baeten JM;
    Sex Transm Dis; 2017 Jan; 44(1):57-61. PubMed ID: 27898566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing Test and Treat in Malawi: health care worker perspectives on barriers and facilitators to ART initiation among HIV-infected clients who feel healthy.
    Dovel K; Phiri K; Mphande M; Mindry D; Sanudi E; Bellos M; Hoffman RM
    Glob Health Action; 2020; 13(1):1728830. PubMed ID: 32098595
    [No Abstract]   [Full Text] [Related]  

  • 30. Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships.
    Mujugira A; Celum C; Thomas KK; Farquhar C; Mugo N; Katabira E; Bukusi EA; Tumwesigye E; Baeten JM;
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):436-42. PubMed ID: 24798765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
    Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
    PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Hurdles on the path to 90-90-90 and beyond": Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat.
    Ayieko J; Brown L; Anthierens S; Van Rie A; Getahun M; Charlebois ED; Petersen ML; Clark TD; Kamya MR; Cohen CR; Bukusi EA; Havlir DV; Camlin CS
    PLoS One; 2018; 13(8):e0202990. PubMed ID: 30161172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Can't you initiate me here?": Challenges to timely initiation on antiretroviral therapy among methadone clients in Dar es Salaam, Tanzania.
    Saleem HT; Mushi D; Hassan S; Bruce RD; Cooke A; Mbwambo J; Lambdin BH
    Int J Drug Policy; 2016 Apr; 30():59-65. PubMed ID: 26831364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barriers and facilitators of retention in HIV care and treatment services in Iringa, Tanzania: the importance of socioeconomic and sociocultural factors.
    Tomori C; Kennedy CE; Brahmbhatt H; Wagman JA; Mbwambo JK; Likindikoki S; Kerrigan DL
    AIDS Care; 2014; 26(7):907-13. PubMed ID: 24279762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR; Wallace M; Bekker LG; Roux S; Atujuna M; Sebastian E; Dye BJ; Elharrar V; Grant RM
    AIDS Behav; 2017 May; 21(5):1361-1375. PubMed ID: 27317411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
    Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
    AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV status and treatment influence on fertility desires among women newly becoming eligible for antiretroviral therapy in western Kenya: insights from a qualitative study.
    Ayieko J; Ti A; Hagey J; Akama E; Bukusi EA; Cohen CR; Patel RC
    Reprod Health; 2017 Aug; 14(1):93. PubMed ID: 28789674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
    Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.